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Detection of Genetic Effects of
Environmental Agents
by Edmond A. Murphy*
The fundamental problems in population monitoring for genetic effects are twofold: the
binomialized nature of the data and the lower power due to small risk of finding positive
results. The binomial character is artificial, even forced, and can with advantage be replaced by
more refined analysis, and by a focus on all mutations, not merely harmful ones. Moreover, a
binomial treatment ignores accessory information (birth order, clustering, etc.). But this
objective requires that an explicit model be used instead of nonparametric methods; a cancer
may represent multiple independent hits that should be separately scored; sequencing of a
codon or its product may show multiple distinct changes.
A sage . . . made the discovery that the flesh of swine . . .
might be cooked . . . without the necessity of consuming the
whole house to dress it.
Charles Lamb: Dissertation on Roast Pig
There is a pompous humility that I deplore in
others, which I am about to represent as a virtue
in myself. One who is not well up in a field is apt to
harp on the very elementary aspects; and such is
our conceit, that we hope that such topics are not
merely elementary, but also elemental. Just so,
the demi monde of mathematics uses florid formu-
las, but the pure mathematician wonders about
obvious things: what "greater than" may mean, or
whether a sheet of paper has two surfaces.
The Problem
The fundamental problem in the whole system of
monitoring for genetic effects in populations seems
to me to reside in two features: first, the data are
more or less binomial in type-that is, they deal
with individuals that either have, or have not,
some particular characteristic; and secondly, the
probability of a successful search, that is, of
finding an aberrant case, is very small, perhaps
one chance in a million or some small multiple
thereof. If we find that, in the face of some
environmental exposure, there are authentic
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increases in these rates that are due neither to
defective sampling nor to the vagaries of chance,
well and good: we are equipped to do battle over
preventive measures. But failing to detect such
changes, we can reassure, or be reassured, only if
our tests have had high enough power. Now in this
context, power means large samples, and large
samples mean trouble. For either we must be
dealing with an abnormality so conspicuous that
the evidence is straightforward and recognition of
all cases assured-stillbirths, sex ratios, multiple
births-measures which will certainly have been
exploited; or we must have an expensive system of
vigilation and endless agonizing over the excel-
lence and uniformity of diagnostic standards. Such
an enterprise is cumbersome, and there must be at
least systematic doubts as to whether it will work
at all. Unfortunately, a cogent system ofvalidation
will, like belling the cat, surely prove at least as
cumbersome as the main enquiry.
My misgivings will no doubt be obvious: that
even with an enormous budget, methods demand-
ing massive samples will not work. If, then, we
are not to go this way, we are driven back on
attacking our two fundamental problems: binomiality
and low spontaneous rates.
Binomiality
Who uses the binomial distribution and why?
The binomial is the simplest of all, nontrivial,
127nondegenerate, distributions. Ifan event had fewer
than two possible, distinct, outcomes, it could not
be random. Now dichotomies of the binomial kind
are imputed in two contexts: penetrating funda-
mentality and crass, even fatuous, naivity. Exam-
ples offundamental binomiality would be existence
and nonexistence, or matter and antimatter, or
positive and negative electrical charges. Examples
of crass binomiality would be "Americans" and
"non-Americans"; or, in the tradition of Sellar and
Yeatman (1), "good kings" and "bad kings." The
essential difference is this: fundamental binomiality
deals with something so near to the limit of our
conceptual resolving power, that we are at a loss
to find a constituent that will furnish any more
basic term of discourse. There are not, for in-
stance, degrees of existence. If something does
not, and cannot, exist it is not an object ofscience.
The gap between existence and its contrary is so
enormous, that all other features assume trivial
proportions. In such cases, we binomialize because
we cannot escape doing so. It is arguable that the
ultimate realities are dichotomous. This topic is
the field ofthe fundamental scientist's fundamental
scientist, the pure mathematician, the philosopher.
Crass binomiality is a less awesome phenome-
non, in which the gap between the two states is
much less wide, and may even be purely construc-
tive. The difference between male and female, so
the activists tell us, is largely fictive; and while
sober scientists may not altogether corroborate
this view, nevertheless we have no criterion ofsex
to which we can appeal for distinguishing unam-
biguously in disputed cases. The difference be-
tween "black" and "white" persons may conceiva-
bly have sociological meaning, but-in the United
States at least-scarcely any biological merit what-
soever. For, insofar as race is a colorimetric term
it is obvious, without any further formal documen-
tation (2), that color behaves as virtually an
uninterrupted variable* and not a dichotomous
one; and if race is a matter of genes, as is usually
implied, studies on genetic admixture have re-
peatedly shown the shallowness of the dichotomy
(3-5). Yet race is still widely used as a crass
binomial character. Crass binomiality is, like as
not, a product of ambition, distraction, uglification
and derision; it pays scant heed to detail, to logical
structure; it is, as we have seen, a kind of dead
end ofstatistical power. It is the tool ofthe lazy; of
the superficial; and of the logically timorous, who
do not wish to venture any surmise that may
prove false.
*Such a variable is often inaccurately termed "continuous."
You will notice that I have crassly binomialized
binomiality itself. In fact, I am quite sure that
there is an uninterrupted ontological scale from
the fundamental to the crass (Table 1). Rating on
the scale of fundamentality-crassness depends on
three features: natural grouping, reproducibility of
the grouping, and the extent to which there exist
more worthwhile and efficient means of assess-
ment. So, to return at last to my topic, we might
wonder where on this scale case-monitoring for
new genetic mutations lies. My own beliefis that it
is towards the crass end ofthe continuum. Let me
try to marshall my arguments.
In the first place, we must have doubts whether,
even at a crass level, binomialization rather than
polytomization, is an adequate description. The
more we look, the more evidence we find of
genetic heterogeneity. Consider, for instance, the
alarming rate at which McKusick's (6), Borgaonkars
(7), and other catalogs are growing; the evidence
of Harris (8), and Boyer (9) on the ubiquity of
chemical polymorphisms, mostly (so far) of struc-
ture and enzymic function; the horrendous diver-
sity of tissue types (10). More and more it grows
on us that not two, but multiple, alleles per locus
may be the rule. Figure how much mutation there
must be, and watch the anxious frowns on the
faces of the population geneticists trying to recon-
cile this profusion with classical theories ofgenetic
load. Then recall that we are crassly dividing our
observations into those with, and those without,
harmful mutations (which, I suppose, wear white
hats and black hats, respectively).
Now, to be sure, if we are to make our infer-
ences from coarse studies on populations-coarse
not from choice but for logistical reasons-why,
we can probably do little better. Or again, if our
sole interest is the assessment of the scale of
damage, the binomial method may do well enough.
But this approach is to ignore mechanisms and
how we may use them to refine our means of
inference. At least one should seriously consider
Table 1. Binomialrepresentation: crassnessandfundamentality.
Fundamentality
Existence Nonexistence
Positive electrical charge Negative electrical charge









Environmental Health Perspectives 128that we may have hold of the wrong end of the
stick. The pragmatic objective of our enquiry is to
prevent harmful mutations; but we should not
confuse the pragmatic objective with the means of
enquiry. Etiologically, the point of the point may
not, perhaps, be the harm, but the mutation. One
concern ofsociety is to prevent fires. But that does
not mean that the only relevant channel of re-
search to prevent them is by counting fires and
looking at when and where they occur, and whatever
crude etiological factors that one might routinely
think up without having any idea of what the
nature of a fire is. The most profitable means
might deal with the comparatively neutral field of
the chemical properties of building materials. I
would not approach prevention of harmful effects
by monitoring harmful effects only. For if muta-
tion is chemically what we believe it to be, is it
necessarily true, is it even plausible, that those
factors that cause deleterious mutations differ from
those that produce neutral, or even beneficial ones?
Power
This line of thought I shall develop further. But
to keep the argument orderly, let us revert to the
second issue, sample size. It is, of course, a
commonplace of epidemiology, that effects are
studied, not simply in proportions but in aggrega-
tions. We know from probability theory, for in-
stance, that the average proportions affected are
not influenced by whether or not cases are mutu-
ally independent. But of course mutual noninde-
pendence is itself valuable evidence of etiology;
indeed, one definition of epidemiology is the study
ofthe nonuniform distribution ofcases in a popula-
tion. Classical genetics has a similar definition: the
study of biological variation. Unfortunately, im-
plementing this definition of quantitative genetics
has been seriously, and perhaps disastrously, blunted
by equating variation with variance.
Now the simple binomialization of data and the
interpretation of them as binomial by the methods
usually employed by the unreflecting, take no
account of nonindependence. To the contrary: the
usual binomial procedures applied glibly to propor-
tions are valid only if (among other conditions) the
outcomes for all units are indeed independent.
Where there is reason to suppose that this as-
sumption is violated, the practice is to retreat into
a subpopulation, for which independence does
seem a warranted assumption, e.g., within a social
class, or an occupation, or a family; and so succes-
sively. But there are logical weaknesses in this
kind of successively conditioned inference.
Crass binomialization may be seen as a nonpar-
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ametric analysis; but even in this "safe" and
conservative field one can do better. Techniques
such as the theory of runs have been devised to
test for serial independence. One of the basic
concerns where outcomes are not independent, is
what the nature of the contagion may be. In
genetics, we would think, for instance, of birth
order. Thus, later members of a sibship are more
likely to be affected by achondroplasia (because of
paternal age); by Down's syndrome (because of
maternal age); by Rh incompatibility (because of
cumulative risk of sensitization); and by birth
injury (because of multiparity and the risk of
precipitate birth). But in congenital syphilis, clus-
tering tends to occur in early pregnancies. Cluster-
ing in middle pregnancies may be due to domicile
(during an intennediate stage ofparental prosperity)
in an area with a high level of some teratogen.
But none of these highly informative patterns
would show up in a crass binomial analysis, in
which the number of affected progeny was re-
garded as sufficient (i.e., an adequately summariz-
ing) statistic.
A natural extension of birth order (which is an
ordering in a discrete, univariate, space) is order-
ing in multiple dimensions. But the foremost of
these, clustering ofresidence or place ofbirth, is a
much more complicated topic for two reasons.
First, it is surprisingly difficult to give an ade-
quate definition ofwhat we mean by a cluster. The
politically unscrupulous, like all wicked people,
have a practical cunning for drawing boundaries in
such a way as to manipulate the outcomes of
elections. And precisely the difficulty of proving
the gerrymander, is the lack of a sufficiently
general theory of clustering against which the
charge can be judged. Granted that we can draw
closed loops, what are reasonable constraints on
the shapes for these loops? Under the null hypothe-
sis of uniform risk, provided that the loops are
drawn beforehand, it does not matter what shapes
they are. But for an unspecified alternate hypothe-
sis where the loops are decided from the outcomes,
interpretation is more difficult. There is a respect-
able theory of clustering (11); but I suppose that
we have at least as much interest in interpreting
the pattern as we have in merely rejecting the null
hypothesis. Besides, the constitution of the alter-
nate hypothesis (as is well known) determines
where the rejection region lies. The null hypothe-
sis might be rejected either because the occur-
rence of cases is too regular or too clumped. If,
regardless ofali etiological factors, precisely every
hundredth child had a particular congenital defect,
the hypothesis of uniform risk would be implausi-
ble. Yet the hypothesis of clustering would be
129even more implausible. We must recognize the
diversity of etiologies: for the unifying thread
might be a toxin distributed down a river valley;
or pollutant in the lee of a factory; or radiation to
houses built on a particular hill; or the flow of
traffic.
The other problem of clustering is the variation
in the density of the population. Under the null
hypothesis of uniform risk, it is clear that (other
things being equal) the expectation of the number
of cases will be proportional to the size of the
population in the area. Even if extreme cold or
dryness are factors, one can hardly expect much of
a cluster at the north pole or the more desolate
parts ofthe Sahara Desert. Ifan acceptible map of
Canada by a projection that conserves area (Fig.
la) were used to plot cases, clusters of almost
anything whatsoever, (even social isolation!) will
tend to occur in the big towns and, in the Western
Provinces, at the most southerly parts, which is
where the population is concentrated. But a rescal-
ing to represent a uniform population density
would allow genuine clusters to show up much
more clearly. The map (Fig. lb) inspired by that of
Skoda and Robertson (12) but much simplified,
could be made ever more refined in detail, so that
all districts of all cities could be individually
identified. Of course maps could be devised, all of
which give uniform population densities, which are
topologically equivalent, but yield different shapes.
We could devise several forms, each designed to
detect certain patterns. For instance, in Figure 2A
is represented an imaginary terrain in which
contour lines are shown with a superimposed grid.
A river is flowing northwards, its descent being
steepest, and therefore its flow fastest, in the
sourthern, more mountainous part ofits course. In
Figure 2B, the repatterned map takes account of
westerly wind, which is strongest in the northern
plains and weakest in the protection of the hills.
The scale is thus contracted from west to east in
the northern part. (The wind has the effect of
scattering and hence "diluting" the concentration
of cases, which must be regathered by crowding
the scale.) In Figure 2C we suppose that the
effects are waterborne, and hence there is great-
est scattering where flow is fastest, just as a dye
in a stream will be dispersed faster and further
down, than across, the stream. Thus the southern
part ofthe river must be foreshortened; and where
density of population for the grid is to be con-
served, the lateral scale must be stretched. These
two distorsions are merely illustrations. Remem-
bering that my topic is genetic effects, we might
capitalize on the fact that human populations tend
to migrate along river valleys, as Cavalli-Sforza
and colleagues (13) demonstrated some years ago.t
Further Increasing the Power
Granted that we have extorted from the data all
the refinement and the ancillary information that
the nonrandomness of the cases may furnish, and
granted that there is a practical limit to the size of
the sample we may hope for, what more can we do
to increase the power? I can think of three
devices.
Increase the Sensitivity
We have already considered how we may do this
by switching the focus from gross and disabling
phenotypes to equivalent random changes of any
kind. The argument here is that the sensitive index
is rate of mutation, not rate of disease. In this
approach, one would be substituting genetic skill
ofthe few specialists fortheunpolarized watchfulness
of the many generalists. The burgeoning field of
analysis of nucleic acids by restriction enzymes
offers enormous promise. But we note three prac-
tical problems that it generates. The investigative
tool is at present technically complex and may
always be so. It remains to be seen whether it will
ever be accessible to, say, the field epidemiologist.
Secondly, to capitalize on power, we will need to
study parents and children, since mutation is co-
gently established by demonstrating genetic content
-in genes or chromosomes-of the offspring that
cannot have been inherited. I need hardly point
out the problems arising from doubtful parentage,
especially paternity. We usually check for this con-
tamination by genetic compatibility ofmarker genes.
But there is a logical trap; for ofcourse we have to
decide how much of any incompatibility may be
ascribed to new mutation, and when we should
abandon this explanation in favor of nonparentage
(15). An obvious device is to exploit the difference
between the degrees of uncertainty about nonpa-
ternity and nonmaternity. (Of course one cannot
ignore the inescapable confounding of any such
effect with biological differences due to the sex of
the disputed parent or to the special impact ofthe
intrauterine milieu.) As we have noted, new muta-
tion appears to increase with paternal age. (How-
ever, does nonpaternity also increase with the hus-
band's age?). One may console oneself with the
tRecently the proceedings ofa workshop on cartography and
epidemiology held in 1976, have been published (14). None of it
seems to be directed to rare events, or (more specifically) to
detecting evidence ofclustering.
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FIGURE 1. Maps of Canada: (a) conventional (zenithal equidistant projection); (b) isodemographic. (This mapping, one of many
possible mappings that are topologically and demographically equivalent, makes the density of the population uniform.) Hence,
under the null hypothesis, that cases occur entirely at random, independently, and at constant risk, their distribution should
follow Roach's probability algebra (11). Systematic departures from this algebra-due to heterogeneity of risk ("hot spots"), to
nonindependence ("contagion"), or to channels of spread (wind, water, food distribution, etc.) will produce typical patterns of
distortion.
December 1981 131pect that the best strategy would be to have epi-
demiologists and biochemists handcuffed together
in symbiotic pairs throughout the entire study.
This step should ensure that as much attention is
paid to the denominator as to the numerator. But,
even so, we would need special supervision to make
sure that they do not corrupt each other. There is
an obvious danger that the epidemiologist may get
interested in the biochemistry, and then all is lost.
B
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FIGURE 2. Etiological mapping. (A). The physically undis-
torted characteristics of an (imaginary) region. As in all
three diagrams, a grid is shown in fine lines, contours of
height in somewhat heavier lines, a river in solid black. The
river rises in the hills in the south (bottom of the diagram),
and flows northwards into a broadening plain, where there
is progressively less physical protection from the prevailing
westerly winds, and airborne factors are more rapidly and
widely disseminated. In the early part of its courase, the
river is falling most rapidly, as represented by the some-
what greater closeness of the contours; hence, linear flow is
also fastest and (for instance) a degradable waterborne
toxin will be more widely spread. (B) Compensatory distor-
tion to offset changing velocity of wind. Areas are con-
served, so that the foreshortening east-west must be
compensated for by extension north-south. (C) Compensa-
tory distortion to offset the changing rate of linear flow in
the river. The latter two mappings should restore homoge-
neity of risk under specific hypotheses. For epidemiological
purposes, it would in general be necessary also to make the
maps isodemographic.
thought that the same distortions are likely to
occur in different groups, and that the strength of
our evidence will lie, not in absolute values, but in
comparisons of otherwise similar groups.
The third snag is, in principle, easily remedia-
ble, but clings, like original sin, to everything we
do. It is the defect that, by some inexorable law of
weakest links, the more refined the studies that
the scientist does in the laboratory, the more care-
lessly he conducts the sampling procedure. I sus-
132
Artificially Increasing the Rate
of Mutation
For any given size ofsample, the variance ofthe
estimate increases as the proportion affected in-
creases from 0% to 50%. Thus the implication of
(say) a 10% difference in the proportions of af-
fected subjects in two samples is least impressive
where the trait is common (Table 2). However,
paradoxically the maximum possible power of a
test for effect may be enhanced by increasing the
larger proportion of positives (Table 2). Could we
then use this strategy? There are three approaches,
each with its own particular problem.
First, experimental studies in man. There seem
to be insurmountable ethical constraints here. I
am not sure that I can defend them formally; but it
is supposed that most mutations are harmful and
the risk ofinducing them unwarranted. It is doubt-
ful that even a volunteer could ethically give con-
sent ex parte for a procedure that may jeopardize
the phenotype of any future progeny.
The second procedure, then, is experimentation
Table 2. Power in comparing proportions in two samples each
of size 1000 from binomial distributions.
Percentage affected Number of
standard errors
Group 1 Group 2 separating the means






















"Ieither in animals or on human tissues in vitro. I
am not sure that I want to get into the ramifications
of such arguments by analogy. But, at least we
have to be concerned about the bland assumption
of proportionate effects. It is an old, and unre-
solved problem as to whether there is indeed a
threshold below which mutation does not occur
(16). By its nature, this problem is difficult to solve
without experiments of immense size. There must
also be some misgiving about the significance of
the response of an isolated tissue. For we know
enough about repair processes in the intact organ-
ism to have considerable doubts about the rele-
vancy ofrates ofbeing affected in one tissue alone.
Skin, for instance, is much more often called upon
than other tissues to repair damage caused by
ultraviolet rays.
The third procedure is to explore the whole prob-
lem at a finely divided level. Radiation of various
types is much more rapidly and efficiently assessed
than the incidence of a disease. If we understood
precisely the mechanism ofaction ofsuch radiation
in mutation, or teratogenesis, we would be able to
resolve our major problem. Of course this pro-
posal has an almost surrealistic qualitv, which will
doubtless not be soon attained. However I raise
the issue purely on principle. Of course, even this
solution depends on intrinsically discrete events
and is hence subject to all the logical shortcomings
of binomialized monitoring of individuals. But the
discreteness is now obtruding at a vastly more
refined level. My moral is that even in a discrete
world we must not assume that at any particular
level of individuation we have hit bedrock in re-
solving power. As I shall suggest presently, there
may be, for instance, something intermediate be-
tween counting phenotypes and counting gamma rays.
Strategic Withdrawal from Crass
Binomiality
So I am led to suggest that we try our best to
break free from binomialization of our data, at
least to the point at which the level ofresolution is
much greater than that with which we are too
often content. There are several methods ofdoing so.
First, and by far the most important, whatever
we can do to impart structure to our crass bino-
mial model, we should do with enthusiasm. To say
how this task is to be done would be to propose a
blueprint for most of modern biology. Even the
most Olympian ambitions of a later speaker would
not aspire to such a goal. But at the least perhaps
I can give a few illustrations of the kind ofthing I
mean.
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In our monitoring system we register each per-
son affected by cancer as a single event; and that
is probably the best we can do on the evidence.
But if we are in a position to impart structure to
this binomialized outcome, we can do better. Sup-
pose, for instance, that we accept the Nordling-
Armitage (7, 8) model that cancer is a multiple-hit
process. Then, rather tritely, it is produced by
multiple events which, ideally, could be individu-
ally counted. If we have, and seize, the opportu-
nity to identify intermediate stages, we may do
much better than by simply counting cancers. For
instance, it is widely held (19) that bowel cancer
occurs only in an antecedent polyp. If it takes one
hit to convert normal bowel into a polyp, and a
second hit to convert the polyp into a cancer, then
we have two events to be scored, not one. The
casual observations of my colleagues in gastroen-
terology are that polyps are perhaps an order of
magnitude more prevalent than cancers. Hence we
have, on this hypothesis, at least two events we
can score, and at present, most epidemiologists
are scoring cancers only, the less common of the
two. But even that is not all. For estimates (20,
21) have suggested that common cancers may be
something like a seven-hit process; and one sup-
poses that, in principle, the several intermediate
stages differ and that each transition may be scored
as an event. Of course, I am not putting all this up
as a finished product, or even as one that I believe
literally. The point is that if we succeed in getting
"inside" the process, we may break through the
binomial barrier into something that is statistically
much more efficient.
But even within the individual patient there may
quite possibly be much more information than we
have tapped. A burning issue at present is whether
multiple polyposis of the colon (a disease in which
we ourselves have a special interest) is monoclonal
or polyclonal. If, as is plausible, it proves to be
polyclonal, then each polyp is a separate event.
Accordingly, we should not merely record whether
or not the patient is affected, but how many polyps
are present. The demonstration of polyclonal ori-
gin depends on having a marker that will Lyonize
(22). The only one widely useful at present is
glucose-6-phosphate dehydrogenase(G6PD)forwhich
there are many readily distinguishable alleles. No
report on the findings for a suitable carrier has yet
been published.
An admirable example of the use of the internal
structure of the model and one on much more
secure footing than bowel cancer (being much more
readily accessible to study) is retinoblastoma. This
tumor used to be called an autosomal dominant
condition with incomplete penetrance (23). This
133more likely than others; that there is degeneracy
in the code; that where amino acids are concerned,
a substitution of serine for proline requires that at
least one event has occurred, ofvaline for argenine,
at least two, and lysine for phenylalanine, at least
three. They should be scored accordingly. As a
concrete example, in Table 3 are given several
descriptor that owes little allegiance to formal anal-
ysis, and none whatsoever to concrete biology.
The way the term has been used by the insouciant
is almost a parody of meaningless pseudo-para-
meterization. Needless to say, any effort to esti-
mate it has, for the most part, been crassly binomial.
Knudson (26, 27) ingeniously converted the phe-
nomenon of retinoblastoma into a two-hit process
which led to explicit predictions about recurrence
risk in relatives of various types, in twins, in uni-
lateral and bilateral cases, etc., which could be
verified, and were. Now this model had two tre-
mendous advantages. It identified a population at
high risk; and that, as we have seen, may enhance
power vastly. Even if we went no further, it must
be evident that such people with heritable cancer
are a natural monitoring device who should receive
intensive study for hazard, an attention which to
my knowledge they have not received. But there
is more. Knudson worked out a quantitative rela-
tionship to the number of retinoblasts (the vulner-
able cells) which agreed with the recurrence ratio.
We might plausibly argue that two physically sep-
arated retinoblastomas in the same eye or, aforti-
orn, one in each eye, constitute two separate events
and may be scored as such.
Pathology abounds in graded systems, devised
for prognosis or to assess therapy, but with which
the etiologist does nothing and, in the absence of
any pathogenetic theory, can do nothing. The der-
matologists, who of all physicians have the most
accessible ofsystems to study, must surely see the
skin as an admirable means for monitoring muta-
genic insults. They talk about skin cancers with a
malignancy of grade 1/2; but surely there must be
some information waiting to be quarried out ofthe
difference between such lesions and more malig-
nant ones? Yet once again, there must presumably
be more information to be extracted from the num-
ber of lesions there are and where exactly they
occur. There must also be added insight from the
(statistical) regression of the number of lesions on
the extent of exposure (see below). Of course, one
gets nothing for nothing; and to extract the infor-
mation efficiently one needs to have some grasp of
the structure ofthe process, and must be prepared
to take some judicious, intellectual, risks by mak-
ing surmises that one is spared in using the crass
binomial. That is what I meant by including the
timorous among the binomializers.
Second, one might do more, perhaps much more,
by capitalizing on relationship of degrees of heter-
ogeneity. It is easy, for instance, to overlook the
difference between systematic and unsystematic
heterogeneity. Regression analysis is more power-
ful than analysis of variance, precisely because,
over and beyond exploring heterogeneity, it makes
use of the information on relationship. The whole
notion of bioassay is based on the idea that the
probability of failure can be stated as an explicit
function of dosage. But clearly this may be im-
proved on. The usual form ascribed to this rela-
tionship has no explicit biological meaning. Why
should the minimum lethal dose of a drug follow a
Gaussian, logistic, or lognormal distribution, and
what pharmacological insight would it furnish if it
did? But let us look at the same problem from the
reverse end. Suppose that we are studying the
effect of a drug, the pharmacodynamics of which
reflects an X-linked polymorphism, such as G6PD
deficiency. If the genetic dose effect is linear,
Lyonization will make the bioassay function a bi-
nomial ofhigh order, which is close to Gaussian. In
Negroes, in whom there is a high rate ofdeficiency,
we would expect to see a bipartite distribution,
and comparison between the shapes of the two
component parts should allow us to separate ge-
netic, from other, sources of variation. I imply
nothing revolutionary about this particular exam-
ple; it is more important as an illustration of the
kind of elucidation that can emerge when the sta-
tistics are adapted to the data rather than the data
to the statistics. Of course one could devise exam-
ples where the dose-response curve is not even
monotonic.
Let us take another tack. A mutation, in the
halcyon days ofplant and Drosophila genetics, and
still in the minds of the environmentalists, is a
phenotypic phenomenon. For the modern molecu-
lar geneticist it is genotypic. And since evolution
leads to, even consists in, progressive divorce be-
tween the genotype and the phenotype, the term
"mutation" becomes more and more ambiguous,
especially in higher organisms. I would venture
the opinion that the almost total estrangement be-
tween the population geneticist and the molecular
biologist, and of both from the internist, is due to
failure to recognize this divorce. Genetic selection
operates on phenotype. But what is inherited is
genotype.
To the environmentalist, a mutation is a muta-
tion is a mutation. But, for instance, we now know
a great deal about point mutation-that is, muta-
Environmental Health Perspectives 134Table 3. Evidence of mutational events in variant hemoglobins.a
Type of Wildtype Mutant type Number of
hemoglobin Chain Position Amino acid Code Amino acid Code mutations
A Beta 6 Glutamic acid GAA Valine GUA 1
C Harlem Beta 6 Glutamic acid GAA Valine GUA 2
Beta 73 Glutamic acid GAA Asparagine AAU
Bristol Beta 67 Valine GU. Aspartic acid GAC 2
Not known - - Phenylalanine uuU Lysine AAA 3
UUL AAG
'The information for this table was kindly furnished by Dr. K. D. Smith.
tion due to substitution of one nucleotide for an-
other. We know that some substitutions are much
term was given no precise meaning. "Penetrance"
has been widely invoked without any attempt to
define its logical properties (24) or without even
any recognition of the fact that whether or not it
has a heritable component makes a fundamental
difference to its pattern ofmanifestation (25). Pene-
trance is an excellent example of a purely external
hemoglobin variants from which variable numbers
of mutations from the wild type may be inferred.
They include an instance of two mutants within
one triplet, and one where there are two mutants
at different amino acids. My colleague, Kirby D.
Smith, who kindly furnished this information, knows
of no hemoglobin recorded so far in which there is
an amino acid substitution that can be explained
only by three or more mutations. We know that
some amino acid substitutions may produce pheno-
typic changes, inconspicuous even by chemical cri-
teria; that the immediate effect of a mutation may
be masked because the mutant is recessive, or
hypostatic to some mutant at another locus. It
must be evident that in bewailing the minute risks
of new mutations and the low power of our moni-
toring, we are starving in the midst of plenty, not
to say opulence.
The facts are a good deal less sure in the de-
tailed analysis ofchromosomes, especially with the
results now available by prophase banding. The
field is at an exploratory stage and, while it is
showing great promise, its formulations are at pres-
ent too unstable for me to make any useful com-
pact statement about it. But when the details are
completed, I am confident that we shall have a tool
at least tenfold more sensitive than what has been
in use in the decade since Casperson introduced
banding.
Conclusion
There is still insufficient recognition, even among
professional epidemiologists, that to binomialize is
the refuge of the destitute, a statistical device to
be avoided at all costs. The basic problem is that it
makes the data two-valued and that in consequence
an absolute upper limit on what we can extract
from the data, is set by the sample size. From a
binomial test, one can never reject a null hypothe-
sis ofp = 1/2 at the 5% level from a sample of size
4. no matter how grossly false the hypothesis. This
limitation does not apply to the z, t, or F distribu-
tions, for instance. There is never any excuse in
serious epidemiology for splitting continuous, uni-
modal, distributions into categories; butmore, there
should be an unceasing drive to convert what ap-
pear to be ineluctably binomial data into data with
biological meaning, logical structure, epidemiologi-
cal import, and statistical power. Until this policy
is tried, or shown to be not merely troublesome
but impossible, I have no tears to shed for our
misfortunes.
From the Division of Medical Genetics, Johns Hopkins Uni-
versity School of Medicine. The research for this paper was
supported under grant number GM24736 of the National Insti-
tutes of Health and a grant from the Julia Baker Fund.
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